Spero Therapeutics, Inc. - stock earnings
SPRO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 51.2 million USD | 71.8 million USD |
| 2023Q3 | -3.2 million USD | 25.5 million USD |
| 2023Q2 | -11.9 million USD | 788000 USD |
| 2023Q1 | -12.3 million USD | 740000 USD |
| 2022Q4 | 26.8 million USD | 46.3 million USD |
| 2022Q3 | -11.5 million USD | 1.1 million USD |
| 2022Q2 | -31.3 million USD | 896000 USD |
| 2022Q1 | -35.5 million USD | 247000 USD |
| 2021Q4 | -29.2 million USD | 2.7 million USD |
| 2021Q3 | -22.5 million USD | 3.1 million USD |
| 2021Q2 | -18.6 million USD | 5.1 million USD |
| 2021Q1 | -19.4 million USD | 7.3 million USD |
| 2020Q4 | -18.6 million USD | 1.9 million USD |
| 2020Q3 | -18.9 million USD | 4.0 million USD |
| 2020Q2 | -17.5 million USD | 1.7 million USD |
| 2020Q1 | -23.3 million USD | 169000 USD |
| 2019Q4 | -25.2 million USD | 696000 USD |
| 2019Q3 | -17.7 million USD | 172000 USD |
| 2019Q2 | -13.2 million USD | 2.2 million USD |
| 2019Q1 | -5.1 million USD | 3.8 million USD |
| 2018Q4 | -10.6 million USD | 1.7 million USD |
| 2018Q3 | -10.5 million USD | 658000 USD |
| 2018Q2 | -10.0 million USD | 463000 USD |
| 2018Q1 | -14.8 million USD | 993000 USD |
| 2017Q4 | -9.8 million USD | 597000 USD |
| 2017Q3 | -9.8 million USD | 597000 USD |
| 2017Q2 | -9.2 million USD | 249000 USD |
| 2017Q1 | -5.9 million USD | 140000 USD |
| 2016Q4 | -7.2 million USD | 335000 USD |
| 2016Q3 | -6.3 million USD | ? USD |
| 2015Q4 | -10.2 million USD | ? USD |
SPRO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 22.8 million USD | 96.7 million USD |
| 2022 | -48.0 million USD | 48.6 million USD |
| 2021 | -91.3 million USD | 18.3 million USD |
| 2020 | -77.5 million USD | 9.3 million USD |
| 2019 | -60.2 million USD | 4.7 million USD |
| 2018 | -41.7 million USD | 4.0 million USD |
| 2017 | -46.1 million USD | 2.0 million USD |
| 2016 | -25.5 million USD | 335000 USD |
| 2015 | -10.2 million USD | ? USD |
SPRO
Price: $1.66
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.43 USD
P/E Ratio: 3.51
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 179389
Market Capitalization: 88.9 million
Average Dividend Frequency: 4